TRANSLATING ACADEMICS TO APPLICATIONS

By Becky OskinTRANSLATING ACADEMICS TO APPLICATIONSToday's basic research transforms tomorrow's medicine and technology.Prenatal ultrasound image of a 12 week gestation fetus during an amniocentesis session. (Image was captured using a GE Voluson 730 Expert Ultrasound with a 3D probe.) Stem cells are more or less the body's blank-canvas cells that can produce virtually any others; they promise huge advances in medicine, perhaps one day even curing spinal injuries and more. There are problems,

Written byBecky Oskin
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Stem cells are more or less the body's blank-canvas cells that can produce virtually any others; they promise huge advances in medicine, perhaps one day even curing spinal injuries and more. There are problems, though: where to get the cells and how to do it under federal funding. A new approach to harvesting stem cells was recently deliniated by Anthony Atala and his colleagues at Wake Forest University School of Medicine's Institute for Regenerative Medicine, along with researchers at the Children's Hospital and Harvard Medical School. This team showed that amniotic fluid donated by pregnant woman contains cells that can develop into mature cell types including liver, brain, and bone. In the long term, says Atala, he hopes that patients needing transplants won't have to wait "for someone to die so they can live."

It took Atala's team seven years to prove the authenticity of their stem cells, but the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies